✦ LIBER ✦

Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia

✍ Scribed by M. Merup; J. Kutti; G. Birgergård; N. Mauritzson; M. Björkholm; B. Markevärn; C. Malm; J. Westin; J. Palmblad; J. Samuelsson; Swedish National Study Group on Chronic Myeloproliferative Disorders

Book ID: 111640866
Publisher: Springer US
Year: 2002
Tongue: English
Weight: 113 KB
Volume: 19
Category: Article
ISSN: 1357-0560
DOI: 10.1385/mo:19:2:79

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide: no benefit in myelofibrosis

Thalidomide: no benefit in myelofibrosis with myeloid metaplasia

✍ Dorothy Bonn 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 106 KB

Low-dose thalidomide effectively treats

Low-dose thalidomide effectively treats advanced myelofibrosis with myeloid metaplasia

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Clinical efficacy and antiangiogenic act

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study

✍ Piccaluga, P P; Visani, G; Pileri, S A; Ascani, S; Grafone, T; Isidori, A; Malag 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 199 KB

Serum erythropoietin in patients with my

Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia

✍ G. Barosi; L. N. Liberato; R. Guarnone 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

Spleen neoangiogenesis in patients with

Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia

✍ Giovanni Barosi; Rosti Vittorio; Massa Margherita; Viarengo G. Luca; Pecci Aless 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

Cytoreductive effect of recombinant alph

Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia

✍ Barosi, G. ;Liberato, L. N. ;Costa, A. ;Ascari, E. 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 393 KB